Archive

What standard annual bloodwork is actually designed to find, why fasting insulin, free T3, IGF-1, hs-CRP, and homocysteine are almost never included despite being among the most clinically meaningful markers available, and what a genuinely comprehensive panel covering 60 plus biomarkers for $99 actually tells you about how your body is functioning.

What autoimmune conditions actually are, why conventional immunosuppressive therapy creates specific challenges for optimization, how LDN's immune modulating mechanism differs from immune suppression, where BPC-157 and gut health interventions fit in the autoimmune context, and how to build a protocol that complements rather than conflicts with disease management.

What cardiovascular aging actually involves at the biological level beyond cholesterol and blood pressure, why arterial stiffness, endothelial dysfunction, and cardiac mitochondrial decline are the more consequential and less addressed mechanisms, how HRV measures autonomic cardiovascular health in real time, and where SS-31, BPC-157, GLP-1 therapy, and NAD+ specifically address these mechanisms.

What Pinealon is, how its ability to cross the blood-brain barrier and interact directly with DNA in neural cell nuclei makes it mechanistically distinct from every other cognitive compound in the catalogue, what the Khavinson research group's findings show about neuroprotection and cognitive aging, and how it fits into the Pinealon/PE22-28/Selank combination.

What oxytocin actually does beyond bonding, how its receptors in cardiac tissue, adipose tissue, immune cells, bone, and the gut produce cardiovascular, metabolic, anti-inflammatory, and bone health effects through mechanisms distinct from every other compound in the catalogue, and why the bonding narrative captures only a fraction of its biological significance.